Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Who should avoid this treatment
Understanding Semaglutide Semaglutide is an FDA-approved GLP-1 receptor agonist designed for chronic weight management in adults dealing with obesity or overweight conditions
It states that clinical evidence supports meaningful weight loss at intermediate dose levels, and that individual response varies substantially with metabolic factors, tolerance, and underlying health status
It's a meaningful distinction worth keeping in mind
In Phase 2 trials, it reduced body weight by up to 24.2%, lowered HbA1c by up to 2.02%, and reduced liver fat by up to 82.4% [1] [2] [5]
Conversely, 5% to 10% experience minimal response below 5% weight loss
US$ 24.03
US$ 28.66
US$ 29.53
